These fragments are products of post-translational proteolytic processing and have previously been described in C2C12 myoblast cells engineered to overexpress GPNMB/OA
These fragments are items of publish-translational proteolytic processing and have earlier been explained in C2C12 myoblast cells engineered to overexpress GPNMB/OA, as properly as in melanocytes and melanoma cells endogenously…